Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1993 Oct;111(2):337–346. doi: 10.1017/s0950268800057046

Impact of respiratory virus infection in patients with chronic chest disease.

M J Wiselka 1, J Kent 1, J B Cookson 1, K G Nicholson 1
PMCID: PMC2271374  PMID: 8405160

Abstract

This study investigated the morbidity associated with respiratory virus infections in patients with well-documented chest disease, and the risk of transmission between close contacts. Patients informed the study team if they were exposed to a family member or colleague with a cold. Patients and symptomatic index cases recorded respiratory symptoms during the study period. Acute nasopharyngeal swabs and paired sera were obtained for viral diagnosis. Twenty-five (43%) of 58 recorded exposures resulted in a symptomatic illness and 16 (28%) patients developed lower respiratory tract symptoms. Sixteen (64%) of the 25 symptomatic patients contacted their general practitioner, 14 (56%) received antibiotics and 4 (16%) were hospitalized. Mean duration of illness was 10.6 days in symptomatic patients and 5.7 days in their corresponding index cases (P < 0.005). Mean symptom scores were 100.6 in symptomatic patients and 62.2 in index cases (P < 0.01). Respiratory viruses were identified in 19 (33%) episodes. Rhinovirus, coronavirus and respiratory syncytial virus infections were all associated with lower respiratory tract exacerbations. Respiratory tract symptoms following exposure to a cold were comparatively severe in these patients with chronic chest disease. This group of patients might gain particular benefit from the introduction of effective vaccines or antiviral therapy.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buscho R. O., Saxtan D., Shultz P. S., Finch E., Mufson M. A. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis. 1978 Apr;137(4):377–383. doi: 10.1093/infdis/137.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Busse W. W. The precipitation of asthma by upper respiratory infections. Chest. 1985 Jan;87(1 Suppl):44S–48S. doi: 10.1378/chest.87.1_supplement.44s. [DOI] [PubMed] [Google Scholar]
  3. Busse W. W. The relationship between viral infections and onset of allergic diseases and asthma. Clin Exp Allergy. 1989 Jan;19(1):1–9. doi: 10.1111/j.1365-2222.1989.tb02336.x. [DOI] [PubMed] [Google Scholar]
  4. CATE T. R., COUCH R. B., FLEET W. F., GRIFFITH W. R., GERONE P. J., KNIGHT V. PRODUCTION OF TRACHEOBRONCHITIS IN VOLUNTEERS WITH RHINOVIRUS IN A SMALL-PARTICLE AEROSOL. Am J Epidemiol. 1965 Jan;81:95–105. doi: 10.1093/oxfordjournals.aje.a120501. [DOI] [PubMed] [Google Scholar]
  5. Carlsen K. H., Orstavik I., Leegaard J., Høeg H. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child. 1984 Apr;59(4):310–315. doi: 10.1136/adc.59.4.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas R. M., Moore B. W., Miles H. B., Davies L. M., Graham N. M., Ryan P., Worswick D. A., Albrecht J. K. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med. 1986 Jan 9;314(2):65–70. doi: 10.1056/NEJM198601093140201. [DOI] [PubMed] [Google Scholar]
  7. Farr B. M., Gwaltney J. M., Jr, Adams K. F., Hayden F. G. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother. 1984 Jul;26(1):31–34. doi: 10.1128/aac.26.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Halperin S. A., Eggleston P. A., Beasley P., Suratt P., Hendley J. O., Gröschel D. H., Gwaltney J. M., Jr Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis. 1985 Nov;132(5):976–980. doi: 10.1164/arrd.1985.132.5.976. [DOI] [PubMed] [Google Scholar]
  9. Hayden F. G., Albrecht J. K., Kaiser D. L., Gwaltney J. M., Jr Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med. 1986 Jan 9;314(2):71–75. doi: 10.1056/NEJM198601093140202. [DOI] [PubMed] [Google Scholar]
  10. Horn M. E., Gregg I. Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis. Chest. 1973 Apr;63(Suppl):44S–48S. doi: 10.1378/chest.63.4_supplement.44s-a. [DOI] [PubMed] [Google Scholar]
  11. Ireland D. C., Kent J., Nicholson K. G. Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR. J Med Virol. 1993 Jun;40(2):96–101. doi: 10.1002/jmv.1890400204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kraaijeveld C. A., Reed S. E., Macnaughton M. R. Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E. J Clin Microbiol. 1980 Oct;12(4):493–497. doi: 10.1128/jcm.12.4.493-497.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Minor T. E., Dick E. C., Baker J. W., Ouellette J. J., Cohen M., Reed C. E. Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis. 1976 Feb;113(2):149–153. doi: 10.1164/arrd.1976.113.2.149. [DOI] [PubMed] [Google Scholar]
  14. Minor T. E., Dick E. C., DeMeo A. N., Ouellette J. J., Cohen M., Reed C. E. Viruses as precipitants of asthmatic attacks in children. JAMA. 1974 Jan 21;227(3):292–298. [PubMed] [Google Scholar]
  15. Mitchell I'Inglis H., Inglis H., Simpson H. Viral infection in wheezy bronchitis and asthma in children. Arch Dis Child. 1976 Sep;51(9):707–711. doi: 10.1136/adc.51.9.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Monto A. S., Albrecht J. K., Schwartz S. A. Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. Antimicrob Agents Chemother. 1988 Jan;32(1):47–50. doi: 10.1128/aac.32.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Monto A. S., Bryan E. R., Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J Infect Dis. 1987 Jul;156(1):43–49. doi: 10.1093/infdis/156.1.43. [DOI] [PubMed] [Google Scholar]
  18. Monto A. S., Higgins M. W., Ross H. W. The Tecumseh study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis. 1975 Jan;111(1):27–36. doi: 10.1164/arrd.1975.111.1.27. [DOI] [PubMed] [Google Scholar]
  19. Monto A. S., Shope T. C., Schwartz S. A., Albrecht J. K. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. J Infect Dis. 1986 Jul;154(1):128–133. doi: 10.1093/infdis/154.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Phillpotts R. J. Clones of MRC-C cells may be superior to the parent line for the culture of 229E-like strains of human respiratory coronavirus. J Virol Methods. 1983 May;6(5):267–269. doi: 10.1016/0166-0934(83)90041-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scott E. J., Grist N. R., Eadie M. B. Rhinovirus infections in chronic bronchitis: isolation of eight possibly new rhinovirus serotypes. J Med Microbiol. 1968 Aug;1(1):109–117. doi: 10.1099/00222615-1-1-109. [DOI] [PubMed] [Google Scholar]
  22. Stuart-Harris C. H. The role of bacterial and viral infection in chronic bronchitis. Arch Environ Health. 1968 Apr;16(4):586–595. doi: 10.1080/00039896.1968.10665107. [DOI] [PubMed] [Google Scholar]
  23. Tarlo S., Broder I., Spence L. A prospective study of respiratory infection in adult asthmatics and their normal spouses. Clin Allergy. 1979 May;9(3):293–301. doi: 10.1111/j.1365-2222.1979.tb01556.x. [DOI] [PubMed] [Google Scholar]
  24. Wang E. E., Prober C. G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1653–1658. doi: 10.1056/NEJM198412273112602. [DOI] [PubMed] [Google Scholar]
  25. Wiselka M. J., Nicholson K. G., Kent J., Cookson J. B., Tyrrell D. A. Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. Thorax. 1991 Oct;46(10):706–711. doi: 10.1136/thx.46.10.706. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES